Tdspharm (464280.KQ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

2.6x

Market Cap

KRW 30.81B

MomentumView details →

1D Return

−1.02%

YTD Return

−40.00%

RSI (14)

51.3

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

2.6x

Market Cap

KRW 30.81B

RSI (14)

51.3

MomentumView details →

1D Return

−1.02%

YTD Return

−40.00%

ProfitabilityView details →

Gross Margin

27.49%

Net Margin

15.67%

EBITDA Margin

19.45%

ROE (TTM)

11.48%

ROA (TTM)

8.09%

Asset Turnover

0.52x

GrowthView details →

Revenue YoY

+43.41%

EPS YoY

+79.55%

FCF YoY

—

Revenue CAGR 3Y

+2.58%

EPS CAGR 3Y

−0.12%

EBITDA YoY

+86.43%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.31x

Current Ratio

2.00x

Quick Ratio

1.78x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

32.90B

Net Income (TTM)

5.15B

Op. CF (TTM)

6.53B

Latest newsMore news →

No recent news for 464280.KQ.

Similar companies

Biogen Inc.BIIB BCWORLD PHARM. Co., Ltd.200780.KQ Metacare Co., Ltd.118000.KS Vigonvita Life Sciences Co., Ltd.02630.HK 通化东宝600867.SH PharmGen Science, Inc.004720.KS Find similar companies →

Latest newsMore news →

No recent news for 464280.KQ.